| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/03/1997 | EP0792360A2 Proteins involved in the regulation of cell-cell adhesion and uses thereof |
| 09/03/1997 | EP0792359A1 Transcription factor e2f-4 |
| 09/03/1997 | EP0792358A2 A polynucleotide tuberculosis vaccine |
| 09/03/1997 | EP0792356A1 Isoflavone reductase promoter |
| 09/03/1997 | EP0792355A1 Method for purifying nucleic acids from homogeneous mixtures |
| 09/03/1997 | EP0792354A1 Targeted t lymphocytes |
| 09/03/1997 | EP0792352A1 Enhanced carotenoid accumulation in storage organs of genetically engineered plants |
| 09/03/1997 | EP0792351A1 Human cell-lines |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | EP0792290A1 Acylated insulin |
| 09/03/1997 | EP0792288A1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 09/03/1997 | EP0792285A1 Process for producing anthracyclines and intermediates thereof |
| 09/03/1997 | EP0792284A1 Novel polypeptides |
| 09/03/1997 | EP0792282A1 Human endothelin-bombesin receptor |
| 09/03/1997 | EP0792281A1 Process for purification of factor viii |
| 09/03/1997 | EP0792279A1 Antibiotic cryptdin peptides and methods of their use |
| 09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
| 09/03/1997 | EP0792169A1 Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors |
| 09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
| 09/03/1997 | EP0792166A1 Internalisation of dna, using conjugates of poly-l-lysine and an integrin receptor ligand |
| 09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 09/03/1997 | EP0792160A1 Glial derived neurotrophic factor as a neuroprotective agent |
| 09/03/1997 | EP0792156A1 Methods for the prevention or treatment of vascular hemorrhaging and alzheimer's disease |
| 09/03/1997 | EP0792155A1 Screening assay for anti-hiv drugs |
| 09/03/1997 | EP0792098A1 Enhancing growth and pearl production in mollusks |
| 09/03/1997 | EP0596885B1 Dna library screening method |
| 09/03/1997 | EP0535242B1 Method and device for determining nucleotide sequence of dna |
| 09/03/1997 | EP0484374B1 Rapid, versatile and simple system for expressing genes in eukaryotic cells |
| 09/03/1997 | CN1158639A DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 09/03/1997 | CN1158638A Mutated penicilling acylase Genes |
| 09/03/1997 | CN1158637A An improved cleaning compsn. |
| 09/03/1997 | CN1158619A Delivery of nucleic acids |
| 09/03/1997 | CN1158617A RNA component of telomerase |
| 09/03/1997 | CN1158552A Cells bearing CD4 decoy receptors and related molecules and methods |
| 09/03/1997 | CN1158357A Gene regulating aureobasidin sensitivity |
| 09/02/1997 | US5663483 Transgenic mice expressing human cholesterol 7αhydroxylase |
| 09/02/1997 | US5663482 Genetic engineering |
| 09/02/1997 | US5663317 Microorganism having attenuated invasiveness |
| 09/02/1997 | US5663312 Chemical intermediates for rna and dna for gene expression |
| 09/02/1997 | US5663304 Refolding of misfolded insulin-like growth factor-I |
| 09/02/1997 | US5663303 Antibodies specific for retinoic acid receptor-γ |
| 09/02/1997 | US5663300 Protocadherin-42 |
| 09/02/1997 | US5663293 ICAM-related protein |
| 09/02/1997 | US5663153 Immune stimulation by phosphorothioate oligonucleotide analogs |
| 09/02/1997 | US5663143 Protein which binds and inhibits elastase |
| 09/02/1997 | US5663142 For treating thrombosis, protein s deficiency, sepsis, inflammation and cancer |
| 09/02/1997 | US5663141 Hirudin/polyalkylene glycol conjugates and hirudin muteins |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| 09/02/1997 | US5663069 Modified lambda bacteriophage |
| 09/02/1997 | US5663068 Cyanobacterial Δ6-desaturase |
| 09/02/1997 | US5663067 Method for cloning and producing the SapI restriction endonuclease in E. coli |
| 09/02/1997 | US5663064 Ribozymes with RNA protein binding site |
| 09/02/1997 | US5663063 Method for producing polyester biopolymers |
| 09/02/1997 | US5663061 Expression vectors for the synthesis of proteins in the fission yeast schizosaccharomyces pombe |
| 09/02/1997 | US5663060 Having procoagulant activity |
| 09/02/1997 | US5663059 Polynucleotide with code, gene expression |
| 09/02/1997 | US5663049 Detection of campylobacter |
| 09/02/1997 | US5663048 Y-chromosome specific polynucleotide probes for prenatal sexing |
| 09/02/1997 | US5663047 Genetic typing |
| 09/02/1997 | US5662917 Release-controlled implantable somatotropin composition |
| 09/02/1997 | US5662906 Non-a non-b hepatitis-specific antigen and its use in hepatitis diagnosis |
| 09/02/1997 | US5662905 Protection against pseudomonas |
| 09/02/1997 | US5662898 Genes for the synthesis of antipathogenic substances |
| 09/02/1997 | US5662897 Isolated and purified recombinant autographa californica nuclear polyhedrosis virus |
| 09/02/1997 | US5662896 Directly administering a vector construct which directs the expression of antitumor agents |
| 09/02/1997 | CA1339414C Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 09/02/1997 | CA1339412C Method for screening an expression cdna clone bank for the detection of polynucleotides |
| 09/02/1997 | CA1339411C Method for screening an expression cdna clone bank for the detection of polynucleotides |
| 08/28/1997 | WO1997031256A2 Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays |
| 08/28/1997 | WO1997031127A1 Technique for representing combinatorial chemistry libraries resulting from selective combination of synthons |
| 08/28/1997 | WO1997031126A1 Methods and reagents for typing hla class i genes |
| 08/28/1997 | WO1997031125A2 Diagnostic method |
| 08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | WO1997031118A1 Production of proteins, plasmids coding therefor and organisms containing such plasmids |
| 08/28/1997 | WO1997031117A2 A human cytomegalovirus combined antigen and its use |
| 08/28/1997 | WO1997031116A2 Recombinant ribonuclease proteins |
| 08/28/1997 | WO1997031115A2 Synthetic hiv genes |
| 08/28/1997 | WO1997031114A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 08/28/1997 | WO1997031113A1 Cell-based assay |
| 08/28/1997 | WO1997031112A2 Compounds and related methods for modulating potassium ion channels and assays for such compounds |
| 08/28/1997 | WO1997031111A2 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them |
| 08/28/1997 | WO1997031110A1 Traf family molecule, polynucleotide coding for the molecule, and antibody against the molecule |
| 08/28/1997 | WO1997031109A1 Meltrins |
| 08/28/1997 | WO1997031108A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | WO1997031107A2 Human serum lectin - induced apoptosis and method for detecting apoptosis |
| 08/28/1997 | WO1997031106A1 Method of changing the composition of the phospholipid produced by the living body and recombinant vector therefor |
| 08/28/1997 | WO1997031105A1 Method for treating biopolymers, microorganisms or materials by using more than one type of magnetic particles |
| 08/28/1997 | WO1997031099A1 Human beta 2 integrin alpha subunit |
| 08/28/1997 | WO1997031024A1 Antibody variants |
| 08/28/1997 | WO1997031018A1 Crystal structure of apopain and uses thereof |
| 08/28/1997 | WO1997031017A1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 08/28/1997 | WO1997031015A1 Rat ob receptors and nucleotides encoding them |
| 08/28/1997 | WO1997031012A1 Gene specific universal mammalian sequence-tagged sites |
| 08/28/1997 | WO1997031010A1 Receptor protein designated 2f1 |
| 08/28/1997 | WO1997030975A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/1997 | WO1997030732A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 08/28/1997 | WO1997030712A1 METHOD FOR INHIBITING NF- kappa B ACTIVATION |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |